Hsu, P., Chang, J. W., Chiu, L., Yang, C., Kuo, S. C., Fang, Y., & Wu, C. (2025). Analysis of genomic alternations in epidermal growth factor receptor (EGFR)-T790M-mutated non-small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib therapy. Clinical and Translational Oncology, 27(5), 1967-1979. https://doi.org/10.1007/s12094-024-03727-7
Chicago-referens (17:e uppl.)Hsu, Ping-Chih, John Wen-Cheng Chang, Li-Chung Chiu, Cheng-Ta Yang, Scott Chih‐Hsi Kuo, Yueh-Fu Fang, och Chiao-En Wu. "Analysis of Genomic Alternations in Epidermal Growth Factor Receptor (EGFR)-T790M-mutated Non-small Cell Lung Cancer (NSCLC) Patients with Acquired Resistance to Osimertinib Therapy." Clinical and Translational Oncology 27, no. 5 (2025): 1967-1979. https://doi.org/10.1007/s12094-024-03727-7.
MLA-referens (9:e uppl.)Hsu, Ping-Chih, et al. "Analysis of Genomic Alternations in Epidermal Growth Factor Receptor (EGFR)-T790M-mutated Non-small Cell Lung Cancer (NSCLC) Patients with Acquired Resistance to Osimertinib Therapy." Clinical and Translational Oncology, vol. 27, no. 5, 2025, pp. 1967-1979, https://doi.org/10.1007/s12094-024-03727-7.
